# Study Evaluating The Co-Administration Of Moxidectin And Midazolam In Healthy Subjects

> **NCT00856362** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 38 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Moxidectin
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT00856362
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2010-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856362, "Study Evaluating The Co-Administration Of Moxidectin And Midazolam In Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00856362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*